11:45-13:15    HALL A

Late Breaking Clinical Trials

Chairs: Rosanna Coppo, Turin, Italy
             Danilo Fliser, Homburg/Saar, Germany

The therapeutic evaluation of steroids in IgA nephropathy global (TESTING) study
Hong Zhang, Beijing, P.R. China
Effect of early versus delayed initiation of renal replacement therapy in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial
Alexander Zarbock, Münster, Germany
Elbasvir/grazoprevir treatment of hepatitis c virus infection in patients with chronic kidney disease stage 4/5: clinical, virologic, and health-related quality of life outcomes in the C-SURFER study
Annette Bruchfeld, Stockholm, Sweden
Lipoprotein(a) - a double-edged sword in cardiovascular disease
Winfried Maerz, Mannheim, Germany
Marsupialized catheter with incremental dialysis dose, key to increased peritoneal dialysis prevalence in elderly
Hilary Riva, Mendrisio, Switzerland


back to the timetable

final programme "day by day" - may 21 - 24, 2016